| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.075 | 0.1 |